Ophthalmology/Eye Diseases

Disease overviews and news and key expert videos focused on rare ophthalmology and eye disorders.

FDA Approves Klygefa (Gefurulimab) for AChR Antibody Positive Generalized Myasthenia Gravis

FDA Approves Klygefa (Gefurulimab) for AChR Antibody Positive Generalized Myasthenia Gravis

The US Food and Drug Administration (FDA) has approved Klygefa (gefurulimab) for the treatment of generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor (AChR) antibody positive. gMG is a chronic autoimmune neuromuscular disease...

Sanofi’s Orphan Drug Supply Update | The CheckRare Brief Special Edition

Sanofi’s Orphan Drug Supply Update | The CheckRare Brief Special Edition

On this special edition of the CheckRare Brief, we talk with Alaa Hamed, Sanofi’s Global Head of Medical Affairs for Rare Diseases, and Maite Durrenbach, Head of Specialty Care Manufacturing and Supply at Sanofi, about the company’s current supply chain problems for some of their biological therapies.

UCB Study Highlights the Burden of Ocular Myasthenia Gravis

UCB Study Highlights the Burden of Ocular Myasthenia Gravis

Anna Kole, Global Patient Engagement Lead for Myasthenia Gravis at UCB, discusses findings from a mixed-methods study examining the experiences and unmet needs of people living with ocular myasthenia gravis (oMG) and explains how patient perspectives could improve clinical research and care.

More

3D Printed Treatment Options | The CheckRare Brief

In this episode, we discuss a new formulation of treatment for HAE, the FDA approval of Voceryq for recurrent respiratory papillomatosis, and 3D printed treatment options.       New...

Ultragenyx Gets $203M in Second Priority Review Voucher This Month | The CheckRare Brief

On this episode, we discuss the FDA approval of Enspryng for TED, the new FDA Rare Disease Framework Initiative, Ultrangenyx’s second sold PRV this month, and using AI to reduce diagnostic delays....

Ultragenyx Sells PRV for $210M | The CheckRare Brief Ep 11

In this episode, we discuss Ultragenyx’s Priority Review Voucher that sold for $210 million, the efficacy of newborn screening on MLD, and ethical considerations needed to design and conduct...

Therapies for MCT8 Deficiency and Nephrotic Syndrome Get FDA Approval | The CheckRare Brief Ep 10

On September 28th, the FDA approved Emcitate, or tiratricol, from Egetis Therapeutics. It's the first-ever treatment for MCT8 deficiency, a condition also known as Allan-Herndon-Dudley syndrome. ...

FDA CDER’s Accelerating Rare Disease Cures Program

Paz Vellanki, MD, PhD, Vice President of Clinical Development at Precision for Medicine, discusses the FDA CDER’s Accelerating Rare Disease Cures (ARC) Program.    The ARC Program was launched...

New Rare Disease Center of Excellence and FDA Advances in Rare Disease | The CheckRare Brief Ep 9

This week on The CheckRare Brief, we are joined by Eugene Lee, CMI Media Group’s Group President, Specialty Communications, for an industry perspective on some of the biggest developments in rare...

FDA Approves New Therapies for MPS IIIA and SMA | The CheckRare Brief Ep 8

This week we discuss the FDA's approval of Isembyld for SMA, the approval of a gene therapy for MPS IIIA, and the FDA's Center for Devices and Radiological Health new Rare Disease Impact...

First-Line Therapy Approved for Rare Lung Cancer | The CheckRare Brief Ep 7

  This week, three developments highlight the rapidly changing rare disease treatment landscape: a Phase 3 setback in Angelman syndrome, continued competition in hereditary angioedema, and an...

New Huntington’s Disease Gene Therapy Application | The CheckRare Brief Ep 6

  In this episode of The CheckRare Brief, we discuss two recent FDA approvals for rare diseases, including Zanvastro for Alexander disease and Besremi for essential thrombocythemia (ET). We...

Data on Maribavir in Post-Transplant Cytomegalovirus

Neil Inhaber, MD, FRCPC, Therapeutic Area Head of Global Medical, Rare Disease at Takeda, discusses data on maribavir in post-transplant cytomegalovirus (CMV) presented at the American Transplant...

New FDA Approvals for Rare Diseases: From Autoimmune Disorders to Pancreatic Cancer | The CheckRare Brief Ep 5

  In this episode of The CheckRare Brief, we discuss four recent FDA approvals, including LISRAYA for dermatomyositis and Imaavy for warm autoimmune hemolytic anemia (wAIHA), Mimrylo for...

Recent Videos

Plasminogen Deficiency: Fibrin Accumulation and Its Effects on Patients

Plasminogen Deficiency: Fibrin Accumulation and Its Effects on Patients

Plasminogen deficiency is caused by variants in the PLG gene and is characterized by the appearance of ligneous fibrin on mucous membranes.

Ophthalmology/Eye Diseases